Institution
University of Erlangen-Nuremberg
Education•Erlangen, Bayern, Germany•
About: University of Erlangen-Nuremberg is a education organization based out in Erlangen, Bayern, Germany. It is known for research contribution in the topics: Population & Immune system. The organization has 42405 authors who have published 85600 publications receiving 2663922 citations.
Topics: Population, Immune system, Breast cancer, Catalysis, Transplantation
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this paper, the anodic formation of nanoporous TiO2 on titanium was investigated in Na2SO4 electrolytes containing low concentrations of NaF (0.1-1/1/5%).
388 citations
••
TL;DR: This work performs a sequence of experimental tests on the same brain specimen to characterize the regional and directional behavior, and supplements these tests with DTI and histology to explore to which extent the macrostructural response is a result of the underlying microstructure.
388 citations
••
TL;DR: Details about members of the monosaccharide transporter and disaccharides transporter families are provided, providing details about their structure, function and regulation.
388 citations
••
Hannover Medical School1, Bernhard Nocht Institute for Tropical Medicine2, University of California, San Francisco3, Systems Research Institute4, University of Veterinary Medicine Vienna5, University of Kiel6, University of Freiburg7, University of Giessen8, University of Marburg9, University of Erlangen-Nuremberg10, University of Bonn11
TL;DR: It was found that recombinant SARS-S bound to ACE2 and induced ACE2 shedding with higher efficiency than NL63-S and replicated efficiently in ACE2-positive Vero cells and reduced ACE2 expression, indicating robust receptor interference in the context of SARS but not NL63 infection.
Abstract: The human coronaviruses (CoVs) severe acute respiratory syndrome (SARS)-CoV and NL63 employ angiotensin-converting enzyme 2 (ACE2) for cell entry. It was shown that recombinant SARS-CoV spike protein (SARS-S) downregulates ACE2 expression and thereby promotes lung injury. Whether NL63-S exerts a similar activity is yet unknown. We found that recombinant SARS-S bound to ACE2 and induced ACE2 shedding with higher efficiency than NL63-S. Shedding most likely accounted for the previously observed ACE2 downregulation but was dispensable for viral replication. Finally, SARS-CoV but not NL63 replicated efficiently in ACE2-positive Vero cells and reduced ACE2 expression, indicating robust receptor interference in the context of SARS-CoV but not NL63 infection.
387 citations
•
26 Oct 1988387 citations
Authors
Showing all 42831 results
Name | H-index | Papers | Citations |
---|---|---|---|
Hermann Brenner | 151 | 1765 | 145655 |
Richard B. Devereux | 144 | 962 | 116403 |
Manfred Paulini | 141 | 1791 | 110930 |
Daniel S. Berman | 141 | 1363 | 86136 |
Peter Lang | 140 | 1136 | 98592 |
Joseph Sodroski | 138 | 542 | 77070 |
Richard J. Johnson | 137 | 880 | 72201 |
Jun Lu | 135 | 1526 | 99767 |
Michael Schmitt | 134 | 2007 | 114667 |
Jost B. Jonas | 132 | 1158 | 166510 |
Andreas Mussgiller | 127 | 1059 | 73778 |
Matthew J. Budoff | 125 | 1449 | 68115 |
Stefan Funk | 125 | 506 | 56955 |
Markus F. Neurath | 124 | 934 | 62376 |
Jean-Marie Lehn | 123 | 1054 | 84616 |